Cargando…
Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective
[Image: see text] Despite mediating several essential processes in the brain, including during development, cyclin-dependent kinase-like 5 (CDKL5) remains a poorly characterized human protein kinase. Accordingly, its substrates, functions, and regulatory mechanisms have not been fully described. We...
Autores principales: | Ong, Han Wee, Liang, Yi, Richardson, William, Lowry, Emily R., Wells, Carrow I., Chen, Xiangrong, Silvestre, Margaux, Dempster, Kelvin, Silvaroli, Josie A., Smith, Jeffery L., Wichterle, Hynek, Pabla, Navjot S., Ultanir, Sila K., Bullock, Alex N., Drewry, David H., Axtman, Alison D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161233/ https://www.ncbi.nlm.nih.gov/pubmed/37084253 http://dx.doi.org/10.1021/acschemneuro.3c00135 |
Ejemplares similares
-
A Potent and Selective CDKL5/GSK3 Chemical Probe is Neuroprotective
por: Ong, Han Wee, et al.
Publicado: (2023) -
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology
por: Castano, Anna, et al.
Publicado: (2023) -
Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics
por: Baltussen, Lucas L, et al.
Publicado: (2018) -
PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor
por: Tamir, Tigist Y., et al.
Publicado: (2020) -
Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia
por: Zavorka Thomas, Megan E., et al.
Publicado: (2021)